RichStorm is an independent research and analysis platform covering the science-driven sectors where analytical depth creates investment opportunity — including pharmaceuticals, biotechnology, supply chain risks, AI infrastructure, and energy. All content is produced for informational and educational purposes only and is based exclusively on publicly available information.

​

The perspective behind the analysis

The analysis published on RichStorm is written by a scientist with doctoral-level training in materials science and engineering — encompassing semiconductor physics, advanced materials, and energy systems — and over a decade of professional experience in the pharmaceutical industry, combined with seven years as a personal investor.

​

That combination — working inside the industry while tracking it as an investor — shapes everything published here. The goal is to bring scientific context to investment questions, and investment thinking to scientific developments, in a way that is grounded in data and honest about uncertainty.

​

What this site covers

RichStorm publishes structured analysis across science-driven investment sectors, including pharmaceutical pipeline analysis, drug development risk frameworks, semiconductor supply chain risks, AI infrastructure economics, sector comparisons, M&A dynamics, and practical investment frameworks for investors seeking deeper engagement with complex, science-intensive industries.

​

What this site is not

RichStorm is not a financial advisory service. Nothing published here constitutes investment advice. RichStorm LLC is not a registered investment adviser. All content is for informational purposes only. Readers should consult a qualified financial adviser before making investment decisions.

​

RichStorm uses artificial intelligence tools to assist with research synthesis and content development. 

 

Get in touch

If you have questions, feedback, or would like to discuss the analysis published here, you can reach us through the contact page.

​

© 2026 RichStorm LLC · All rights reserved · Not investment advice